Breaking News

Ajinomoto Completes Althea Acquisition

April 5, 2013

Will operate under the name Ajinomoto Althea

Ajinomoto Co., Inc. has completed its acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services, for approximately $175 million. Althea will become a fully consolidated subsidiary of Ajinomoto Co. operating under the company name Ajinomoto Althea, Inc.

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016